Wei He

4.5k total citations
134 papers, 2.9k citations indexed

About

Wei He is a scholar working on Molecular Biology, Hepatology and Surgery. According to data from OpenAlex, Wei He has authored 134 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 37 papers in Hepatology and 28 papers in Surgery. Recurrent topics in Wei He's work include Hepatocellular Carcinoma Treatment and Prognosis (37 papers), Liver Disease Diagnosis and Treatment (19 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers). Wei He is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (37 papers), Liver Disease Diagnosis and Treatment (19 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers). Wei He collaborates with scholars based in China, United States and United Kingdom. Wei He's co-authors include Yunfei Yuan, Binkui Li, Jiliang Qiu, Denis C. Guttridge, Yun Zheng, Ruhai Zou, Dinglan Zuo, Yuanping Zhang, Priya Londhe and Alessandro Canella and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Clinical Investigation.

In The Last Decade

Wei He

126 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei He China 27 1.3k 797 606 558 526 134 2.9k
Han Wu China 31 808 0.6× 625 0.8× 709 1.2× 527 0.9× 298 0.6× 92 2.5k
Juan Xia China 32 1.4k 1.0× 775 1.0× 355 0.6× 601 1.1× 216 0.4× 159 3.1k
Kaishan Tao China 31 1.5k 1.1× 921 1.2× 422 0.7× 646 1.2× 194 0.4× 108 2.9k
Nathalie Théret France 37 1.4k 1.1× 649 0.8× 607 1.0× 755 1.4× 329 0.6× 87 3.4k
Xingxing He China 32 2.1k 1.6× 1.4k 1.7× 393 0.6× 600 1.1× 451 0.9× 80 3.9k
Minjiang Chen China 35 1.8k 1.3× 903 1.1× 360 0.6× 1.1k 2.0× 1.2k 2.2× 197 4.0k
Zhipeng Han China 32 1.5k 1.1× 811 1.0× 372 0.6× 966 1.7× 282 0.5× 71 3.6k
Junli Guo China 32 1.2k 0.9× 448 0.6× 314 0.5× 398 0.7× 229 0.4× 96 2.4k
Kohichi Takada Japan 28 1.7k 1.3× 468 0.6× 219 0.4× 854 1.5× 469 0.9× 172 3.7k

Countries citing papers authored by Wei He

Since Specialization
Citations

This map shows the geographic impact of Wei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei He more than expected).

Fields of papers citing papers by Wei He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei He. The network helps show where Wei He may publish in the future.

Co-authorship network of co-authors of Wei He

This figure shows the co-authorship network connecting the top 25 collaborators of Wei He. A scholar is included among the top collaborators of Wei He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei He. Wei He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Yunxing, Kai Li, Yichuan Yuan, et al.. (2024). Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma. Cancer Cell International. 24(1). 138–138. 2 indexed citations
2.
Shi, Yunxing, Dinglan Zuo, Yi Niu, et al.. (2024). Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling. Nature Communications. 15(1). 7930–7930. 19 indexed citations
3.
He, Wei, et al.. (2024). Artificial Intelligence-Powered Construction of a Microbial Optimal Growth Temperature Database and Its Impact on Enzyme Optimal Temperature Prediction. The Journal of Physical Chemistry B. 128(10). 2281–2292. 2 indexed citations
4.
Wang, Chenwei, Liang Qiao, Yichuan Yuan, et al.. (2024). Prognosis predictors of hepatocellular carcinoma after hepatectomy following conversion therapy. European Journal of Surgical Oncology. 51(1). 109375–109375.
5.
6.
7.
Zhang, Jing, et al.. (2023). MicroRNA-181b attenuates lipopolysaccharide-induced inflammatory responses in pulpitis via the PLAU/AKT/NF-κB axis. International Immunopharmacology. 127. 111451–111451. 6 indexed citations
8.
He, Wei, et al.. (2023). Record‐High Work‐Function p‐Type CuBiP2Se6 Atomic Layers for High‐Photoresponse van der Waals Vertical Heterostructure Phototransistor. Advanced Materials. 35(14). e2209995–e2209995. 20 indexed citations
9.
Wang, Maoyu, Qing Chen, Yi Wang, et al.. (2023). Comprehensive identification of onco-exaptation events in bladder cancer cell lines revealed L1PA2-SYT1 as a prognosis-relevant event. iScience. 26(12). 108482–108482. 5 indexed citations
10.
Qiu, Qiang, Yuanyuan Sun, Qingqing Li, et al.. (2023). TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN. Signal Transduction and Targeted Therapy. 8(1). 90–90. 6 indexed citations
11.
Dimopoulos, Meletios Α., Vânia Hungria, Atanas Radinoff, et al.. (2023). S199: A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF SINGLE AGENT BELANTAMAB MAFODOTIN VS POMALIDOMIDE PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (DREAMM-3). HemaSphere. 7(S3). e072005a–e072005a. 2 indexed citations
12.
He, Wei, Gabriella S Lamb, Don Goldmann, et al.. (2022). Interferon Gamma Release Assay Results and Testing Trends Among Patients Younger Than 2 Years Old at Two US Health Centers. The Pediatric Infectious Disease Journal. 42(3). 189–194. 1 indexed citations
13.
Jiang, Lingmin, Wei He, Jiliang Qiu, et al.. (2022). More Liver Metastases Detected Intraoperatively Indicates Worse Prognosis for Colorectal Liver Metastases Patients after Resection Combined with Microwave Ablation. Journal of Oncology. 2022. 1–8. 2 indexed citations
14.
Li, Kai, Yi Niu, Yichuan Yuan, et al.. (2022). Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling. Oncogene. 41(23). 3197–3209. 13 indexed citations
15.
Campbell, Jeffrey I., Wei He, Bethany Hedt‐Gauthier, et al.. (2022). Multicenter Analysis of Attrition from the Pediatric Tuberculosis Infection Care Cascade in Boston. The Journal of Pediatrics. 253. 181–188.e5. 4 indexed citations
16.
Zhang, Yuanping, Wei He, Chuan Peng, et al.. (2021). Long-term outcome for colorectal liver metastases: combining hepatectomy with intraoperative ultrasound guided open microwave ablation versus hepatectomy alone. International Journal of Hyperthermia. 38(1). 372–381. 4 indexed citations
17.
Faivre, Emily J., Denise Wilcox, Xia Li, et al.. (2016). Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075. Molecular Cancer Research. 15(1). 35–44. 53 indexed citations
18.
Qiu, Jiliang, Yun Zheng, Jingxian Shen, et al.. (2015). Resection versus ablation in hepatitis B virus−related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study. Surgery. 158(5). 1235–1243. 14 indexed citations
19.
Lan, Ruzhu, et al.. (2013). Prevention effect of CAUTI by long-acting antibacterial material JUC : a meta-analysis. Zhonghua miniao waike zazhi. 34(1). 50–52. 1 indexed citations
20.
Zha, Jikun, Ke-Jun Han, Liang‐Guo Xu, et al.. (2006). The Ret Finger Protein Inhibits Signaling Mediated by the Noncanonical and Canonical IκB Kinase Family Members. The Journal of Immunology. 176(2). 1072–1080. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Han Wu Breakdown of academic impact, for papers by Juan Xia Breakdown of academic impact, for papers by Kaishan Tao Breakdown of academic impact, for papers by Nathalie Théret Breakdown of academic impact, for papers by Xingxing He Breakdown of academic impact, for papers by Minjiang Chen Breakdown of academic impact, for papers by Zhipeng Han Breakdown of academic impact, for papers by Junli Guo Breakdown of academic impact, for papers by Kohichi Takada
Rankless by CCL
2026